| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |